Studies discussed in this article
| AURA Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-124)5 |
| EOS Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease Patients Treated With Salmeterol (BY217/M2-127)4 |
| HELIOS Effect of Roflumilast in Chronic Obstructive Pulmonary Disease) Patients Treated With Tiotropium (BY217/M2-128)4 |
| HERMES Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-125)5 |
| RATIO Effect of 1-Year Treatment With Roflumilast in Severe Chronic Obstructive Pulmonary Disease3 |
| REACT Effect Of Roflumilast On Exacerbations In Patients With Severe Chronic Obstructive Pulmonary Disease Uncontrolled By Combination Therapy: A Multicentre Randomised Controlled Trial6 |
| RECORD Roflumilast—An Oral Anti-inflammatory Treatment for Chronic Obtructive Pulmonary Disease: A Randomised Controlled Trial1 |